To further state the importance of DTX2 and HSF2 in determining the sensitivity of the chemotherapy and PI3K-mTOR inhibitors, the colon cancer cells were divided into drug sensitive or resistant subtypes based on the scale of drug LN-IC50. This evidence concerns the gene PIK3CA and malignant colon neoplasm.